Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Acetonide-loaded Nanoparticles For Nasal Postoperative Application
NCT07714525Phase 2Recruiting
- Sponsor
- Deraya University
- Start
- May 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in chronic rhinosinusitis (CRS), nasal polyps, sponsored by Deraya University. Started May 2026; status: recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
chronic rhinosinusitis (CRS)nasal polyps
Beyond the preview
Go deeper on NCT07714525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07714525.